tirzepatide and chills Deaths Does Mounjaro Make You Cold?

GLP-1s in CKD: Evidence, market leadership, and key insights from ASN 2025 At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with more than 70 sessions, posters, and oral abstracts probing their role across the kidney-disease continuum, and even a dedicated mention during the opening plenary talk

There is a lot of debate about MDMA's potential neurotoxicity and whether its a concern for human users

The SURMOUNT-5 results are not surprising, said Avlin Imaeda, MD, PhD, associate professor of digestive diseases and medical director of the North Haven Endoscopy Center at Yale School of Medicine

doi:10.1016/j.smrv.2016.06.005

Sun H, Shu J, Tang J, et al

Is Uncommon Beauty a clean beauty brand